Jun 11, 2020
Almirall Enters the IBEX 35
Jan 09, 2020
Almirall signs a strategic agreement with 23andMe to license rights of a bispecific monoclonal antibody that blocks all three isoforms of IL-36 cytokine
Jan 09, 2020
Almirall enters into an option agreement to acquire Bioniz Therapeutics and to establish a broad research agreement to further expand its innovative pipeline in medical dermatology
Jul 25, 2019
Almirall Issues Call For Grant Submissions For Development of New Immunodermatology Therapies
Mar 04, 2019
Almirall and Athenex Announce Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting
Mar 04, 2019
Almirall enters into a definitive agreement to divest ThermiGen, its medical device aesthetics business
Feb 05, 2019
Almirall Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting
Oct 19, 2018
Almirall LLC Launches New Name at Fall Clinical Dermatology Congress
Sep 21, 2018
Almirall acquires Allergan U.S. medical dermatology portfolio*
Sep 04, 2018
THERMI® LAUNCHES ARVATI(TM), powered by Thermi®, with newest advances in True Temperature Controlled Radiofrequency Technology
Jun 06, 2018
Thermi's Temperature-Controlled Radiofrequency System Improved Common Vaginal Disorders And Sexual Function, Published Study Shows
Feb 26, 2018
Thermi announces new clinical education and enhanced training platforms for clinicians
Feb 22, 2018
Thermi and Sinclair terminate their collaboration on Silhouette Instalift(TM)